Drug Database
Back to search

United Kingdom· GB-APID-32689711000001101

Rixubis 500unit powder and solvent for solution for injection vials

A nonacog gamma product containing nonacog gamma, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 3 of our 19 countries.

ATC B02BD29

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRixubis 500unit powder and solvent fo…ATCB02BD29REGISTER NO.GB-APID-3268971100000…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nonacog gammaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nonacog gamma is registered in 3 of 19 countries.

Countries holding a registration under ATC B02BD29 (nonacog gamma), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose
Search nonacog gamma products by name

Nonacog gamma · ATC B02BD29

3 / 19 countries

  • Franceprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Nonacog gamma
Manufacturer
Takeda UK Ltd
Country
United Kingdom (GB)
ATC code
B02BD29
ATC class
Nonacog gamma
Defined daily dose
800 E, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    00642621025682

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nonacog gamma in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nonacog gamma products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Benefix, Rixubis
  • Liechtenstein · Benefix, Rixubis
  • Norway · Benefix, Rixubis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/adefa960-c551-4e06-aeb4-9cdcb3e0c971
GET /v1/drugs/adefa960-c551-4e06-aeb4-9cdcb3e0c971?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "32689711000001101",
  "desc": "Rixubis 500unit powder and solvent for solution for injection vials (Takeda UK Ltd)",
  "form": "Powder and solvent for solution for injection",
  "vpid": "32689611000001105",
  "source": "dmd",
  "vtm_id": "32689111000001102",
  "strength": "500 unit",
  "substance": "Nonacog gamma",
  "ingredient": "Nonacog gamma",
  "supplier_code": "3811601000001107"
}
API referenceMCP serverPlans

See everything about nonacog gamma.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console